PLTR: Palantir Technologies Inc. - Class A Common Stock
Holding · 2.0% · trim (from 13.9%) · mega · Technology · last 196.75
Entry — · Stop — · Target — · Sell ≈ 30 shares (≈ $5,902 at 196.75)
Avoid thesis on valuation (F-PLTR-7). Keep a 2% stake: sell it if Q3 revenue on 11/2 comes in below the $2.164B top of guidance, or on a close below $180.
Thesis (avoid, position, conviction 58)
Bull: Fundamentals are genuinely exceptional: Q2 2026 revenue grew 93% YoY to $1.935B with US commercial revenue up 149% YoY to $764M, GAAP operating margin of 47% and net margin of 55% (F-PLTR-1, F-PLTR-2, F-PLTR-3, F-PLTR-4), and the balance sheet carries $9.2B in cash/short-term treasuries with no net debt drag (F-PLTR-5). Management raised FY2026 guidance to $8.15-8.16B and guided Q3 2026 revenue to $2.16-2.164B, both implying continued high-double-digit growth (F-PLTR-6, F-PLTR-7), a steep acceleration from FY2025's $4.475B (F-PLTR-8). Q2 EPS of $0.41 beat estimates by 15.7% (F-PLTR-12), and sell-side sentiment is skewed bullish (28 buy/strong-buy vs 2 sell-side ratings, F-PLTR-13). Price action is strong: trading above both the 20-day ($195.51) and 200-day ($153.15) moving averages, only 5.9% off the 52-week high, with a 3-month return of 49.6% and relative strength vs SPY of 46.5% (F-PLTR-9, F-PLTR-10, F-PLTR-11), and RSI14 at 54 shows no overbought exhaustion.
Bear: Valuation is detached from any conventional anchor: trailing P/E sits at 156-174x depending on source, with the brief itself unable to reconcile the two figures (data gap noted), meaning even a modest growth deceleration or margin normalization could trigger a severe multiple contraction. Revenue growth is already decelerating on a sequential basis — Q3 2026 guidance of $2.16-2.164B implies roughly 87% YoY growth versus Q2's 93% (F-PLTR-1, F-PLTR-7), and markets pricing a story at this multiple are unforgiving of any deceleration. A director sold ~$1.0M of stock on October 8, 2026, and the brief cannot confirm whether this was a scheduled 10b5-1 sale or discretionary (F-PLTR-14), an ambiguous but unhelpful signal layered on top of stretched pricing. The position is also already a large 13.9% portfolio weight, meaning incremental capital here concentrates single-name/valuation risk rather than diversifying it. At ~28% above the 200-day moving average, the stock has limited margin of safety against any macro wobble or AI-spending sentiment shift, and GAAP profitability, while real, is still a small fraction of the market cap implied by the current multiple.
Valuation: On the only valuation metric the brief supplies, PLTR trades at 156-174x trailing GAAP EPS of roughly $0.41/quarter annualized — the brief does not provide a forward P/E, FCF yield, or multiple comparison to growth (PEG), so there is no clean cross-check, but a mid-150s to mid-170s trailing P/E against ~90% revenue growth that is itself decelerating sequentially (93% in Q2 vs implied ~87% in Q3 guidance) leaves very little room for error. This is priced for sustained hyper-growth and margin expansion with no visible discount for execution risk.
Catalysts
2026-11-02: Q3 2026 earnings report; analyst consensus is $2.224B revenue and $0.4231 EPS, versus company guidance of $2.160-2.164B revenue — a beat/miss or guide-down here will be the key near-term valuation test
2027-02-01: Q4 2026 earnings report, which will show whether the sequential growth deceleration trend from Q2 to Q3 continues or reverses
Facts
F-PLTR-1: Palantir reported Q2 2026 revenue of $1.935 billion for the quarter ended June 30, 2026, up 93% year over year. (as of 2026-08-03)[E7284]source
F-PLTR-2: U.S. commercial revenue was $764 million in Q2 2026, up 149% year over year. (as of 2026-08-03)[E7284]source
F-PLTR-3: GAAP operating income was $912 million in Q2 2026, a 47% margin. (as of 2026-08-03)[E7284]source
F-PLTR-4: GAAP net income was $1.062 billion in Q2 2026, a 55% margin. (as of 2026-08-03)[E7284]source
F-PLTR-5: Palantir reported $9.2 billion in cash, cash equivalents, and short-term U.S. Treasury securities as of its Q2 2026 results announcement. (as of 2026-08-03)[E7284]source
F-PLTR-6: On August 3, 2026, Palantir raised its full-year 2026 revenue guidance to $8.150–$8.158 billion. (as of 2026-08-03)[E7284]source
F-PLTR-7: For Q3 2026, Palantir forecast revenue of $2.160–$2.164 billion in its August 3, 2026 results release. (as of 2026-08-03)[E7284]source
F-PLTR-8: For calendar 2025, Palantir reported revenue of $4.475 billion, compared with $2.866 billion for calendar 2024. (as of 2026-10-23)[E7271]
F-PLTR-9: PLTR closed at $196.75 on October 23, 2026, 5.9% below its 52-week closing high. (as of 2026-10-23)[E6807]
F-PLTR-10: As of October 23, 2026, PLTR's three-month return was 49.6%, and its three-month relative strength versus SPY was 46.5%. (as of 2026-10-23)[E6807]
F-PLTR-11: PLTR's 20-day moving average was $195.51 and its 200-day moving average was $153.15 on October 23, 2026. (as of 2026-10-23)[E6807]
F-PLTR-12: Palantir's Q2 2026 diluted EPS of $0.41 exceeded the $0.3544 estimate by 15.7%. (as of 2026-10-23)[E6828]
F-PLTR-13: The October 2026 analyst recommendation tally was 12 strong buys, 16 buys, 9 holds, 1 sell, and 1 strong sell. (as of 2026-10-01)[E7273]
F-PLTR-14: A news report stated that director Lauren Elaina Friedman Stat sold 5,026 PLTR shares on October 8, 2026, for about $1.0 million. (as of 2026-10-14)[E6823]source
Critic
O4 (major): The 2% retention is smaller, but still lacks an affirmative upside case consistent with the avoid thesis. Open: PLTR cut further to 2% with explicit sell rules on Q3 revenue or a close below 180; the upside case stays contested.
What would change the view
A close below the 200-day moving average (~$153) without a clear growth deceleration catalyst would signal the valuation is becoming disconnected from price support, raising concern
Q3 2026 revenue print materially above $2.164B guidance with reaccelerating YoY growth back toward or above 93% would meaningfully strengthen the bull case and could flip this to long
Confirmation that the trailing P/E is reliably closer to the lower 150x (Finnhub) figure rather than 174x, combined with forward guidance implying a sub-100x forward multiple, would ease the valuation concern
A second consecutive quarter of sequential revenue growth deceleration (YoY growth rate declining both Q2-to-Q3 and Q3-to-Q4) would reinforce avoid
Data quality
Quality score 100/100.
Gap: Trailing P/E estimates differ between the supplied Yahoo-derived and Finnhub data (174.12 versus 156.73); the pack does not reconcile the calculation dates or methods. [E6808]
Gap: The quote block timestamp is October 24, 2026, after the stated analysis date of October 23, 2026, so it was not used for the October 23 closing-price fact. [E6806]
Red flag: A news report stated that director Lauren Elaina Friedman Stat sold 5,026 shares for about $1.0 million on October 8, 2026; the supplied report does not establish whether this was part of a scheduled trading plan. [E6823]